Company Monitoring Page for Exelixis

latest headlines for company on cafepharma

After a long march with Cabo, Exelixis is expanding its focus with an antibody-drug conjugate deal
Endpoints
Thu, 05/16/19 - 10:25 am
Tags:
Exelixis, Cabometyx, ICON-2, Iconic Therapeutics, antibody-drug conjugate
Where Will Gilead Sciences Spend Its Cash?
Motley Fool
Tue, 05/7/19 - 10:03 am
Tags:
Gilead Sciences, M&A, Atara, Exelixis
Exelixis initiates phase 3 trial of cabozantinib in advanced renal cell carcinoma
Pharmaceutical Business Review
Thu, 05/2/19 - 11:20 am
Tags:
Exelixis, clinical trials, cabozantinib, Cabometyx, advanced renal cell carcinoma
3 Cancer Treatment Stocks on a Growth Trend
Motley Fool
Sun, 04/21/19 - 10:33 pm
Tags:
Geron, AbbVie, Exelixis, cancer
Exelixis Proves Being Second Can Work Out Well
Motley Fool
Wed, 02/13/19 - 05:04 pm
Tags:
Exelixis, Bristol-Myers Squibb, Cabometyx, kidney cancer
Exelixis (EXEL) to Report Q4 Earnings: What's in Store?
Yahoo/Zacks.com
Fri, 02/8/19 - 09:26 am
Tags:
Exelixis, earnings
FDA approves Cabometyx for liver cancer
BioCentury
Mon, 01/14/19 - 11:59 pm
Tags:
Exelixis, Ipsen, Cabometyx, liver cancer, FDA
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
Tags:
clinical trials, Takeda, Zinfandel Pharmaceuticals, pioglitazone, Alzheimer's disease, Boehringer Ingelheim, BI 409306, Merck, verubecestat, Celgene, MS, ozanimod, Incyte, ID01, melanoma, vTv Therapeutics, azeliragon, Roche, Tecentriq, Exelixis, colorectal cancer, JNJ, atabacestat, Sareptat Therapeutics, DMD, Exondys 51, Alkermes, ALKS-5461, clinical depression
Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market
Motley Fool
Tue, 11/6/18 - 09:34 am
Tags:
Exelixis, earnings, kidney cancer, Cabometyx
Why Merck's Latest Success Means Trouble for Exelixis Inc.
Yahoo/Motley Fool
Fri, 10/19/18 - 09:13 am
Tags:
Merck, Exelixis, Cabometyx, Keytruda
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
CP Wire
Mon, 10/8/18 - 09:55 am
Tags:
Exelixis, Cabometyx, thyroid cancer
Mon, 10/8/18 - 09:25 am
Tags:
Exelixis, Cabometyx, thyroid cancer
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
CP WIre
Fri, 09/21/18 - 10:02 am
Tags:
Exelixis, Ipsen, Cabometyx, hepatocellular carcinoma
Fri, 09/21/18 - 09:42 am
Tags:
Exelixis, Ipsen, Cabometyx, hepatocellular carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
CP Wire
Wed, 09/19/18 - 11:27 am
Tags:
Exelixis, Cabometyx, Takeda, Canada, Japan, Ipsen, renal cell carcinoma
Wed, 09/19/18 - 09:16 am
Tags:
Exelixis, Ipsen, Cabometyx
National Comprehensive Cancer Network Releases New Guidelines for Cabometyx for Advanced Renal Cell Carcinoma
CP Wire
Fri, 09/7/18 - 11:05 am
Tags:
Exelixis, Cabometyx, advanced renal cell carcinoma
Fri, 09/7/18 - 09:44 am
Tags:
Exelixis, Cabometyx, advanced renal cell carcinoma
Exelixis Gets the Patients Eventually
Motley Fool
Mon, 08/6/18 - 11:47 pm
Tags:
Exelixis, kidney cancer, renal cell carcinoma, Cabometyx
Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
CP Wire
Fri, 06/1/18 - 09:55 am
Tags:
Exelixis, clinical trials, Cabometyx, Tecentriq

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.